What do patients and doctors really want from lung cancer drugs?
NCT ID NCT07413757
Summary
This study aims to understand what matters most to patients and doctors when choosing first-line treatments for advanced lung cancer. Researchers will survey 590 Chinese patients and physicians who have experience with these treatments. The survey asks participants to make choices between different treatment options to reveal their preferences for factors like effectiveness and side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGChengdu, 610000, China
Conditions
Explore the condition pages connected to this study.